Remove Containment Remove Filler Remove Gene
article thumbnail

Crescita Announces Licensing Agreement for Pliaglis; in China

The Pharma Data

Relying on independent research and development, the Company has formed gene recombination and fermentation engineering technology, and developed a number of core technologies, such as recombinant collagen, enzymatic and genetic engineering synthesis of bioactive peptides. For additional information, please visit [link].